Compositions and Methods for Targeted Delivery to Cells
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,121,610 | Compositions and Methods for Targeted Delivery to Cells In force · Low confidence | Recode Therapeutics, Inc. | In force | Low confidence | ||
| Application 18/311,274 | Compositions and Methods for Targeted Delivery to Cells Abandoned Abandoned May 15, 2026 | Recode Therapeutics, Inc. | Abandoned | Abandoned May 15, 2026 | not computed | |
| Application 18/312,305 | Compositions and Methods for Targeted Delivery to Cells Abandoned Abandoned Apr 20, 2026 | Recode Therapeutics, Inc. | Abandoned | Abandoned Apr 20, 2026 | not computed | |
| Application 18/778,429 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Recode Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 18/778,439 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Recode Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 18/778,717 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Recode Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 18/778,746 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Recode Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 18/780,382 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Recode Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 18/797,360 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Recode Therapeutics, Inc. | Pending | Not granted | not computed | |
| Application 18/283,344 | Compositions and Methods for Targeted Delivery to Cells Pending Not granted | Board of Regents, the University of Texas System | Pending | Not granted | not computed |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Recode Therapeutics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.